(Q38176703)

30 August 2017

title

Novel inhibitors of the Plasmodium falciparum electron transport chain (English)

1 reference

30 August 2017

main subject

Plasmodium falciparum

0 references

author

Giancarlo Biagini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

P A Stocks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

V Barton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

T Antoine

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

S A Ward

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

P M O'Neill

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

1 January 2014

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

50-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401337%20AND%20SRC:MED&resulttype=core&format=json

Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Antimalarial activity of WR 243251, a Dihydroacridinedione

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Dual binding mode of a novel series of DHODH inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Inhibiting Plasmodium cytochrome bc1: a complex issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Inhibitors of the mitochondrial electron transport chain and de novo pyrimidine biosynthesis as antimalarials: The present status

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Genome sequence of the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

The global pipeline of new medicines for the control and elimination of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Chapter 17 Type II NADH: quinone oxidoreductases of Plasmodium falciparum and Mycobacterium tuberculosis kinetic and high-throughput assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Identification and characterization of small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

The malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Reoptimization of MDL keys for use in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Antimalarial pharmacology and therapeutics of atovaquone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Artemisinin Resistance in Plasmodium falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Structural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical Scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Mitochondrial drug targets in apicomplexan parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

PowerMV: a software environment for molecular viewing, descriptor generation, data analysis and hit evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Drug-like properties and the causes of poor solubility and poor permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Evaluation and lead optimization of anti-malarial acridones

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Synthesis and antimalarial properties of 1-imino derivatives of 7-chloro-3-substituted-3,4-dihydro-1,9(2H,10H)-acridinediones and related structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Functional characterization and target validation of alternative complex I of Plasmodium falciparum mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Molecular basis for atovaquone binding to the cytochrome bc1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Discovery of dual function acridones as a new antimalarial chemotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Rapid method for the estimation of octanol/water partition coefficient (log P(oct)) from gradient RP-HPLC retention and a hydrogen bond acidity term (zetaalpha(2)(H)).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

7 January 2021

A research agenda for malaria eradication: drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

7 January 2021

Conformationally linked interaction in the cytochrome bc(1) complex between inhibitors of the Q(o) site and the Rieske iron-sulfur protein

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

7 January 2021

The antimalarial activity of some quinolone esters

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

7 January 2021

Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

7 January 2021

Potent antimalarial 4-pyridones with improved physico-chemical properties

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

7 January 2021

Quinolone-3-diarylethers: a new class of antimalarial drug.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

7 January 2021

Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro

1 reference

https://api.crossref.org/works/10.1017%2FS0031182013001571

7 January 2021

10.1017/S0031182013001571

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7hk6wbq34vedrfx4otkvgpmjt4

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_7hk6wbq34vedrfx4otkvgpmjt4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7hk6wbq34vedrfx4otkvgpmjt4

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/7hk6wbq34vedrfx4otkvgpmjt4

1 reference

30 July 2022